DAS28 remission and clinical efficacy in rheumatoid arthritis patients with inadequate responses to methotrexate treated with abatacept: The Phase III AIM trial and a Phase IIB trial long-term extension

被引：0
|
作者：
Westhovens, R
Kremer, J
Shergy, W
Abud-Mendoza, C
Aranda, R
Becker, JC
Zhou, Y
Mokliatchouk, O
Dougados, M
机构：
[1] Univ Hosp Gasthuisberg, Louvain, Belgium
[2] Ctr Rheumatol, Albany, NY USA
[3] Albany Med Coll, Albany, NY 12208 USA
[4] Rheumatol Assoc N Alabama, Huntsville, AL USA
[5] Hosp Cent Ignac Morones Prieto, San Luis Potosi, Mexico
[6] Bristol Myers Squibb Co, Princeton, NJ USA
[7] Hosp Cochin, Paris, France
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [31] DAS28 (ESR) Response at Week 12 is Predictive of Long-Term Disease Activity in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
    Schiff, Michael
    Keystone, Edward
    Kvien, Tore
    Curtis, Jeffrey
    Emery, Paul
    Luijtens, Kristel
    Choy, Ernest
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1332 - 1332
  • [32] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Tanaka, Yoshiya
    Wada, Kazuteru
    Takahashi, Yoshinori
    Hagino, Owen
    van Hoogstraten, Hubert
    Graham, Neil M. H.
    Kameda, Hideto
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [33] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Yoshiya Tanaka
    Kazuteru Wada
    Yoshinori Takahashi
    Owen Hagino
    Hubert van Hoogstraten
    Neil M. H. Graham
    Hideto Kameda
    Arthritis Research & Therapy, 21
  • [34] DAS28 and decrease of serum osteoprotegerin from baseline level represent parameters predicting long-term efficacy intliximab plus methotrexate treatment in rheumatoid arthritis patients.
    Ziolkowska, M
    Wiland, P
    Szechinski, J
    Sliwinska, P
    Pazdur, J
    Rupinski, R
    Filipowicz-Sosnowska, A
    Maslinski, W
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S135 - S135
  • [35] Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study
    Iwahashi, Mitsuhiro
    Inoue, Hiroshi
    Matsubara, Tsukasa
    Tanaka, Takaaki
    Amano, Koichi
    Kanamono, Toshihisa
    Nakano, Teruaki
    Uchimura, Shoichi
    Izumihara, Tomomaro
    Yamazaki, Akira
    Karyekar, Chetan S.
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2014, 24 (06) : 885 - 891
  • [36] Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension
    Kimball, Alexandra B.
    Luger, Thomas
    Gottlieb, Alice
    Puig, Luis
    Kaufmann, Roland
    Burge, Russel
    Lin, Chen-yen
    Yosipovitch, Gil
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (01) : 98 - 102
  • [37] Effect of Methotrexate Dose on the Efficacy of Tofacitinib: Treatment Outcomes from a Phase 3 Clinical Trial of Patients with Rheumatoid Arthritis
    Fleischmann, Roy
    Mease, Philip J.
    Schwartzman, Sergio
    Hwang, Lie-Ju
    Patel, Aditya
    Soma, Koshika
    Connell, Carol A.
    Takiya, Liza
    Bananis, Eustratios
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [38] EFFECT OF METHOTREXATE DOSE ON THE EFFICACY OF TOFACITINIB: TREATMENT OUTCOMES FROM A PHASE 3 CLINICAL TRIAL OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Fleischmann, R.
    Mease, P.
    Schwartzman, S.
    Hwang, L. -J.
    Soma, K.
    Connell, C.
    Takiya, L.
    Bananis, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 258 - 259
  • [39] Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Yoshiya Tanaka
    Kazuteru Wada
    Yoshinori Takahashi
    Owen Hagino
    Hubert van Hoogstraten
    Neil M. H. Graham
    Hideto Kameda
    Arthritis Research & Therapy, 21
  • [40] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
12345